Literature DB >> 25368159

The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.

Tohru Tezuka1, Akane Inoue1, Taisuke Hoshi1, Scott D Weatherbee2, Robert W Burgess3, Ryo Ueta1, Yuji Yamanashi4.   

Abstract

The motoneural control of skeletal muscle contraction requires the neuromuscular junction (NMJ), a midmuscle synapse between the motor nerve and myotube. The formation and maintenance of NMJs are orchestrated by the muscle-specific receptor tyrosine kinase (MuSK). Motor neuron-derived agrin activates MuSK via binding to MuSK's coreceptor Lrp4, and genetic defects in agrin underlie a congenital myasthenic syndrome (an NMJ disorder). However, MuSK-dependent postsynaptic differentiation of NMJs occurs in the absence of a motor neuron, indicating a need for nerve/agrin-independent MuSK activation. We previously identified the muscle protein Dok-7 as an essential activator of MuSK. Although NMJ formation requires agrin under physiological conditions, it is dispensable for NMJ formation experimentally in the absence of the neurotransmitter acetylcholine, which inhibits postsynaptic specialization. Thus, it was hypothesized that MuSK needs agrin together with Lrp4 and Dok-7 to achieve sufficient activation to surmount inhibition by acetylcholine. Here, we show that forced expression of Dok-7 in muscle enhanced MuSK activation in mice lacking agrin or Lrp4 and restored midmuscle NMJ formation in agrin-deficient mice, but not in Lrp4-deficient mice, probably due to the loss of Lrp4-dependent presynaptic differentiation. However, these NMJs in agrin-deficient mice rapidly disappeared after birth, and postsynaptic specializations emerged ectopically throughout myotubes whereas exogenous Dok-7-mediated MuSK activation was maintained. These findings demonstrate that the MuSK activator agrin plays another role essential for the postnatal maintenance, but not for embryonic formation, of NMJs and also for the postnatal, but not prenatal, midmuscle localization of postsynaptic specializations, providing physiological and pathophysiological insight into NMJ homeostasis.

Entities:  

Keywords:  Dok-7; Lrp4; neuromuscular junction; postsynaptic specialization

Mesh:

Substances:

Year:  2014        PMID: 25368159      PMCID: PMC4246289          DOI: 10.1073/pnas.1408409111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Sleuthing molecular targets for neurological diseases at the neuromuscular junction.

Authors:  Andrew G Engel; Kinji Ohno; Steven M Sine
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

2.  LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction.

Authors:  Scott D Weatherbee; Kathryn V Anderson; Lee A Niswander
Journal:  Development       Date:  2006-12       Impact factor: 6.868

3.  A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals.

Authors:  Hiroshi Nishimune; Joshua R Sanes; Steven S Carlson
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

4.  Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK.

Authors:  Boris A Hesser; Oliver Henschel; Veit Witzemann
Journal:  Mol Cell Neurosci       Date:  2005-12-07       Impact factor: 4.314

5.  The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.

Authors:  Kumiko Okada; Akane Inoue; Momoko Okada; Yoji Murata; Shigeru Kakuta; Takafumi Jigami; Sachiko Kubo; Hirokazu Shiraishi; Katsumi Eguchi; Masakatsu Motomura; Tetsu Akiyama; Yoichiro Iwakura; Osamu Higuchi; Yuji Yamanashi
Journal:  Science       Date:  2006-06-23       Impact factor: 47.728

6.  Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals.

Authors:  Michael A Fox; Joshua R Sanes; Dorin-Bogdan Borza; Veraragavan P Eswarakumar; Reinhard Fässler; Billy G Hudson; Simon W M John; Yoshifumi Ninomiya; Vadim Pedchenko; Samuel L Pfaff; Michelle N Rheault; Yoshikazu Sado; Yoav Segal; Michael J Werle; Hisashi Umemori
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

7.  Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter.

Authors:  Thomas Misgeld; Terrance T Kummer; Jeff W Lichtman; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

8.  Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism.

Authors:  Weichun Lin; Bertha Dominguez; Jiefei Yang; Prafulla Aryal; Eugene P Brandon; Fred H Gage; Kuo-Fen Lee
Journal:  Neuron       Date:  2005-05-19       Impact factor: 17.173

9.  MuSK controls where motor axons grow and form synapses.

Authors:  Natalie Kim; Steven J Burden
Journal:  Nat Neurosci       Date:  2007-12-16       Impact factor: 24.884

10.  Dok-7 mutations underlie a neuromuscular junction synaptopathy.

Authors:  David Beeson; Osamu Higuchi; Jackie Palace; Judy Cossins; Hayley Spearman; Susan Maxwell; John Newsom-Davis; Georgina Burke; Peter Fawcett; Masakatsu Motomura; Juliane S Müller; Hanns Lochmüller; Clarke Slater; Angela Vincent; Yuji Yamanashi
Journal:  Science       Date:  2006-08-17       Impact factor: 47.728

View more
  19 in total

1.  Influencing Early Stages of Neuromuscular Junction Formation through Glycocalyx Engineering.

Authors:  Mia L Huang; Ember M Tota; Taryn M Lucas; Kamil Godula
Journal:  ACS Chem Neurosci       Date:  2018-08-28       Impact factor: 4.418

2.  Congenital myasthenic syndrome-associated agrin variants affect clustering of acetylcholine receptors in a domain-specific manner.

Authors:  Bisei Ohkawara; XinMing Shen; Duygu Selcen; Mohammad Nazim; Vera Bril; Mark A Tarnopolsky; Lauren Brady; Sae Fukami; Anthony A Amato; Uluc Yis; Kinji Ohno; Andrew G Engel
Journal:  JCI Insight       Date:  2020-04-09

3.  Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis.

Authors:  Zhiguo Li; Minshu Li; Kristofer Wood; Steffan Hettwer; Suraj A Muley; Fu-Dong Shi; Qiang Liu; Shafeeq S Ladha
Journal:  Muscle Nerve       Date:  2018-01-08       Impact factor: 3.217

4.  Enterovirus-A71 exploits peripherin and Rac1 to invade the central nervous system.

Authors:  Ze Qin Lim; Qing Yong Ng; Yukei Oo; Justin Jang Hann Chu; Shi Yan Ng; Siu Kwan Sze; Sylvie Alonso
Journal:  EMBO Rep       Date:  2021-04-19       Impact factor: 9.071

Review 5.  Bone morphogenetic protein signaling in vertebrate motor neurons and neuromuscular communication.

Authors:  Nelson Osses; Juan P Henríquez
Journal:  Front Cell Neurosci       Date:  2015-01-27       Impact factor: 5.505

6.  Overlapping Mechanisms of Peripheral Nerve Regeneration and Angiogenesis Following Sciatic Nerve Transection.

Authors:  Hongkui Wang; Hui Zhu; Qi Guo; Tianmei Qian; Ping Zhang; Shiying Li; Chengbin Xue; Xiaosong Gu
Journal:  Front Cell Neurosci       Date:  2017-10-11       Impact factor: 5.505

7.  The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.

Authors:  Gang Chen; Hefen Yu; Lucy Satherley; Catherine Zabkiewicz; Jeyna Resaul; Huishan Zhao; Hu Mu; Xiuyi Zhi; Junqi He; Lin Ye; Wen G Jiang
Journal:  Oncol Rep       Date:  2017-03-31       Impact factor: 3.906

Review 8.  Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders.

Authors:  Masaharu Takamori
Journal:  Int J Mol Sci       Date:  2017-04-24       Impact factor: 5.923

Review 9.  The CNS/PNS Extracellular Matrix Provides Instructive Guidance Cues to Neural Cells and Neuroregulatory Proteins in Neural Development and Repair.

Authors:  James Melrose; Anthony J Hayes; Gregory Bix
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

10.  The role of Sema3-Npn-1 signaling during diaphragm innervation and muscle development.

Authors:  Maximilian Michael Saller; Rosa-Eva Huettl; Philipp Hanuschick; Anna-Lena Amend; Paolo Alberton; Attila Aszodi; Andrea B Huber
Journal:  J Cell Sci       Date:  2016-07-27       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.